Routine health screening market developments and opportunities through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Routine Health Screening Market Expected To Scale Between 2026 And 2030?

The routine health screening market has experienced substantial growth in recent years. It is projected to expand from $58.45 billion in 2025 to $62.9 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 7.6%. Historically, this market expansion can be attributed to increasing public health awareness, the expansion of diagnostic laboratory networks, a rising incidence of chronic diseases, improved access to basic healthcare services, and growing employer-sponsored health screening initiatives.

The routine health screening market is projected to experience substantial expansion in the coming years, reaching a valuation of $83.35 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This anticipated growth is primarily driven by factors such as the increasing embrace of personalized preventive care, a heightened demand for diagnostics that can be performed remotely or at home, the broadening scope of digital health platforms, the growing implementation of advanced screening technologies, and a stronger focus on managing population health. Key trends during this period are expected to include a rise in preventive health screening initiatives, wider adoption of at-home diagnostic testing, enhanced integration of digital health records, a concentrated effort on early disease detection, and improved access to routine screening services.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20618&type=smp

Which Drivers Are Supporting The Routine Health Screening Market Growth?

The routine health screenings market is anticipated to expand due to the growing recognition of preventive healthcare. This type of healthcare involves strategies and actions designed to avert the development or advancement of illnesses and medical conditions through early identification, changes in lifestyle, and proactive medical approaches. Heightened awareness stems from its advantages, such as discovering diseases early, achieving superior health results, and financial savings, all propelled by advances in public education and medical science. Regular health check-ups support preventive healthcare efforts by spotting potential health problems in their initial stages, enabling prompt treatment, and decreasing the likelihood of serious illnesses. As an illustration, figures from May 2023 reported by the National Health Service (NHS), a UK-based publicly funded healthcare system, showed that 2,302,400 diagnostic tests were carried out in March 2023, representing an increase of 223,100 tests when contrasted with March 2022. By the close of March 2023, the count of individuals awaiting a critical diagnostic test hit 1,628,300, signifying an increment of 59,400 over March 2022. Consequently, the heightened understanding of preventive healthcare is stimulating expansion within the routine health screenings market.

Which Segment Classifications Are Used In The Routine Health Screening Market Segment Analysis?

The routine health screening market covered in this report is segmented –

1) By Test Type: Blood Glucose Test, Kidney Function Test, Bone Profile Test, Electrolyte Test, Liver Function Test, Lipid Profile Test, Other Test Types

2) By Sample Type: Blood, Urine, Serum, Saliva, Other Sample Types

3) By Technology: Quantitative Polymerase Chain Reaction (QPCR), Quantitative Fluorescence In Situ Hybridization (Q-FISH), Immunoassays, Medical Imaging, Single Telomere Length Analysis (STELA), Other Technologies

4) By Sample Collection Sites: Hospitals, Homes, Diagnostic Laboratories, Offices, Other Sample Collection Sites

Subsegments:

1) By Blood Glucose Test: Fasting Blood Glucose Test, HbA1c Test, Continuous Glucose Monitoring

2) By Kidney Function Test: Serum Creatinine Test, Blood Urea Nitrogen (BUN) Test, Urinalysis

3) By Bone Profile Test: Serum Calcium Test, Phosphate Test, Bone Mineral Density (BMD) Test

4) By Electrolyte Test: Serum Sodium Test, Serum Potassium Test, Serum Chloride Test

5) By Liver Function Test: Alanine Aminotransferase (ALT) Test, Aspartate Aminotransferase (AST) Test, Bilirubin Test

6) By Lipid Profile Test: Total Cholesterol Test, Low-Density Lipoprotein (LDL) Test, High-Density Lipoprotein (HDL) Test

7) By Other Test Types: Thyroid Function Test, Complete Blood Count (CBC), Prostate-Specific Antigen (PSA) Test

Which Trends Are Expected To Impact The Routine Health Screening Market?

Leading companies in the routine health screenings market are concentrating on developing advanced solutions, such as lung cancer screening tests, to gain a competitive edge. Lung cancer screening tests are medical evaluations crafted to detect lung cancer at an early stage in high-risk individuals, even before symptoms manifest. For example, in October 2023, DELFI Diagnostics Inc., a US-based diagnostic technology company, introduced FirstLook Lung, an innovative blood test designed to enhance lung cancer screening. This test utilizes fragmentomics to analyze patterns in cell-free DNA (cfDNA) from blood samples and employs advanced machine learning to differentiate between cancerous and non-cancerous patterns. With a 99.7% negative predictive value (NPV), the test efficiently identifies potential lung cancer cases while minimizing the requirement for unnecessary low-dose CT (LDCT) scans. Integrated into routine blood tests, FirstLook Lung aims to improve screening rates, particularly among underserved groups, and features a scalable whole-genome machine-learning platform with the capacity for global expansion into other cancers and treatment monitoring.

Which Firms Are Contributing To The Routine Health Screening Market Ecosystem?

Major companies operating in the routine health screening market are Roche Holding AG, Thermo Fisher Scientific Inc., Siemens Healthineers, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Hologic Inc., Illumina Inc., SYNLAB International GmbH, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, RadNet Inc., Opko Health Inc., UNILABS, Amedes Holding GmbH, Natera Inc., Grail Inc., Trinity Biotech PLC, Cerba HealthCare S.A.S., Quidel Corporation, Innova Medical Group

Get The Full Routine Health Screening Market Report:

https://www.thebusinessresearchcompany.com/report/routine-health-screening-global-market-report

Which Region Represents The Largest Share Of The Routine Health Screening Market?

North America was the largest region in the routine health screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the routine health screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Routine Health Screening Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/routine-health-screening-global-market-report

Browse Through More Reports Similar to the Global Routine Health Screening Market 2026, By The Business Research Company

Connected Healthcare Market Report 2026

https://www.thebusinessresearchcompany.com/report/connected-healthcare-global-market-report

Consumer Healthcare Market Report

https://www.thebusinessresearchcompany.com/report/consumer-healthcare-global-market-report

Poultry Healthcare Market Report

https://www.thebusinessresearchcompany.com/report/poultry-healthcare-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795